Search for: "DISCOVERY HOUSE, INC" Results 1041 - 1060 of 1,172
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jun 2019, 1:41 pm by Vishnu Kannan
Tuesday, June 25, 2019, 2:00 p.m.: The House Committee on Foreign Affairs will hold a hearing titled “The U.S. [read post]
1 Aug 2011, 6:03 am by Stephen Albainy-Jenei
Patent Docs‘ Kevin Noonan talks about the latest case in which the Federal Circuit assessed the scope of foreseeability for rebutting prosecution history estoppel, Duramed Pharmaceuticals, Inc. v. [read post]
20 Jun 2008, 8:07 am
– Comments on IPEG post on Zyprexa patent case: (BLOG@IP::JUR) India takes open source approach to drug discovery: (Patent Lens), India: Is the Indian Drug Controller participating in the ACTA negotiations? [read post]
15 Jun 2012, 11:30 am by William McGrath
In a Motion to Suppress and a Motion to Dismiss, the defendants raised issues regarding DOJ's relationship with Control Components, Inc. [read post]
1 Sep 2011, 5:10 pm by INFORRM
IMS Health Inc (23 June 2011) in which the Court voted 6-3 to strike down Vermont’s Prescription Confidentiality Law, which had prohibited the use, sale or disclosure of prescriber histories in pharmaceutical marketing to physicians. [read post]
27 Jun 2008, 10:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
1 Apr 2019, 12:07 pm by Cynthia Marcotte Stamer
  Businesses Urged To Comment Positively On Proposed NLRB Joint Employment Rule By 12/13/18; NLRB Responds To House  Democrats About Private Contractor Participation In Joint Employment Rule Comment Processing. [read post]
11 Jul 2008, 4:30 am
: (IAM), (Patent Circle), India takes open source approach to drug discovery: (Patent Lens), India: Indian Bayh Dole Bill: (Spicy IP), (Spicy IP), (Does India need Bayh-Dole? [read post]
18 Jun 2010, 3:58 am by Rebecca Tushnet
Also it’s confidential, and there’s no discovery. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
25 Apr 2017, 3:21 pm by Cynthia Marcotte Stamer
Spring Clean Your Health Plan House Since any reforms eventually enacted are unlikely to retroactively eliminate liability of employers, their health plans or fiduciaries for violations of federal health plan mandates, health plan terms, or associated contracts occurring before the effective date of reform, employer and other health plan sponsors, fiduciaries, insurers and administrators should begin by identifying,  cleaning up any existing, unresolved, and preventing any new health… [read post]
29 Feb 2020, 5:38 am
For example, Alcoa Corp. recently noted supply chain bottlenecks in China for critical resources; Apple, Inc. announced that it would not meet its 2ndquarter financial guidance; Boston Scientific expected revenues from sales to China to be significantly affected; Best Buy expected difficulty in product availability from goods sources in China for much of 2020; and luxury brands seller Capri Holdings expected the sale of its goods worldwide to be negatively affected (What Apple, Microsoft,… [read post]